Thoratec Corporation (Thoratec) is a manufacturer of circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets products that are used by physicians and hospitals for cardiac assist, vascular and diagnostic applications. Thoratec operates in two business segments: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. Cardiac assist and vascular graft products represented 61% of Thoratec's product sales during the fiscal year ended December 29, 2007, (fiscal 2007). Point-of-care blood diagnostics test systems and services and incision products amounted to 39% of the Company's total product sales in 2007.
Thoratec Corporation
NASDAQ:THOR ISIN:US8851753074
ニュース
先週金曜日のオーストラリア株式は値を上げて取引を終え、トラブルに陥った米国ホームオーナーへの救援策に米国政府が取り組んでいるという報道を受けて一週間を上昇でまとめた。S&P/オーストラリア証券取引所200銘柄の基準指数は44.8ポイント・1.27%上昇の3,559.1、全株価指数は38.2ポイント・1.1%上昇の3,496.7ポイントとなった。オバマ政権は金融危機を手っ取り早く解決することへの期待を冷ますことに取り組んでおり、今後の業績報告は市場をマイナス領域へ送り込む可能性がある。
###
54,702 会社概要の閲覧回数
- 日本語ページ閲覧回数: (過去7日間: 12) (過去30日間: 45) (発行以降: 9744)